MARKET

ARRY

ARRY

Array Biopharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

47.85
0.00
0.00%
Delisted 09:30 11/20 EST
OPEN
--
PREV CLOSE
47.29
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
47.98
52 WEEK LOW
12.56
MARKET CAP
10.61B
P/E (TTM)
-81.2394
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ARRY and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 8 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ARRY News

  • Heres How Pfizer Stock (and Pharma) Stand to Benefit From Mylan Deal
  • InvestorPlace.07/31 10:01
  • Array Shares To No Longer Trade As Pfizer Is Taking Over The Co.
  • Benzinga.07/30 12:21
  • Array BioPharma Shares Halted For Info Requested By Exchange
  • Benzinga.07/30 12:18
  • The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings
  • Benzinga.07/30 11:43

More

Industry

Biotechnology & Medical Research
+0.65%
Pharmaceuticals & Medical Research
-0.14%

Hot Stocks

Name
Price
%Change

About ARRY

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. The Company's programs include approximately three cancer drugs, binimetinib, encorafenib and selumetinib (partnered with AstraZeneca, PLC). Its binimetinib and encorafenib are in Phase III trials in advanced cancer patients, including the COLUMBUS trial studying encorafenib in combination with binimetinib in patients with BRAF-mutant melanoma and has initiated BEACON CRC trial to study encorafenib in combination with binimetinib and cetuximab in patients with BRAF V600E-mutant colorectal cancer (BRAFm CRC). Its selumetinib is a mitogen-activated protein kinase (MEK) inhibitor for cancer, which is in Phase III trial. Its advanced clinical-stage drugs include Filanesib, ARRY-797, ASC08/Danoprevir, Ipatasertib/GDC-0068, Motolimod/VTX-2337, LOXO-101, ONT-380/ARRY-380, GDC-0575, GDC-0994 and ARRY-382.
More

Webull offers Array Biopharma Inc (ARRY) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.